Toward an End-to-End Biologics Repository & Analysis Platform
Bio-IT World, Boston, MA, USA
April 18, 2021
Over the past two years, a team has been developing a comprehensive Biotherapeutics Informatics platform to centralize the storage of information and data for sequences, potential liabilities, assays, inventory, and other project- and group-specific information. The platform — now in use across multiple groups and sites — is built around the Genedata Biologics commercial software package, which we have supplemented with Pfizerproprietary computational methodology and have integrated into Pfizer’s biotherapeutic R&D workflows. This poster highlights some of the current work involved in developing this infrastructure as a key enabler of our End-to-End biologics strategy.